NK cells in these haploidentical HSCTs mediate a graft versus leukemia effect if alloreactive educated NK cells respond to absence of ligands for inhibitory KIR on leukemia cells, leading to a reduced risk of leukemia relapse [95,96,97]. Here, KIR3DL1 is linked to leukemia.